News & Press
Helpful Information on Canine Lymphoma (Cancer in Dogs)
How to Keep an Aging Dog Comfortable at Home
Elanco Announces Agreements with Aratana Therapeutics and VetDC, Creates Specialty Veterinary Business Focus
TANOVEA-CA1 Canine Lymphoma Treatment Delivers Excellent Results for Stella
Reason for Hope as We Observe National Canine Lymphoma Awareness Day
GUEST POST: NorthStar VETS Uses TANOVEA-CA1 for Canine Lymphoma Patients
Have You Considered Pet Insurance? A Brief Overview.
(Video) VCS Interview with Dr. Andrew Novosad
VetDC Announces New TANOVEA®-CA1 Publication, State of the Art Presentation at VCS 2017 Annual Conference
FORT COLLINS, Colo.–(BUSINESS WIRE)–VetDC, Inc., the leading veterinary cancer therapeutics company, today announced a new TANOVEA®-CA1 (rabacfosadine for injection) publication in Veterinary & Comparative Oncology. Data from this publication and several new VetDC-sponsored studies was prominently featured in a State …